Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide and Diet in Idiopathic Intracranial Hypertension
NCT01003639Phase 3Completed
- Sponsor
- St. Luke's-Roosevelt Hospital Center
- Start
- Jan 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of acetazolamide in idiopathic intracranial hypertension (IIH), sponsored by St. Luke's-Roosevelt Hospital Center. Started Jan 2010; status: completed.
02
Drugs
acetazolamide
03
Conditions
idiopathic intracranial hypertension (IIH)
Beyond the preview
Go deeper on NCT01003639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01003639.